Last updated on September 2016

CONVERGE


Brief description of study

CONVERGE

Detailed Study Description

This study is evaluating 2 different treatment options for persistent atrial fibrillation. In this multi-center, pivotal clinical study, patients are randomized (2:1) to either a convergent procedure that includes both epicardial and endocardial atrial ablation versus standalone endocardial catheter ablation. The study will enroll and randomize one hundred and fifty three (153) patients from up to thirty (30) sites with twenty-seven (27) in the US and three (3) sites OUS.

Clinical Study Identifier: TX145279

Find a site near you

Start Over

Austin Heart PLLC

Located in: Austin, TX USA
  Connect »

Summa Health System

Located in: Akron, OH USA
  Connect »

Lahey Clinic

Located in: Burlington, MA USA
  Connect »

Genesys Regional Medical Center

Located in: Grand Blanc, MI USA
  Connect »

Heart Center Research LLC

Located in: Huntsville, AL USA
  Connect »

St. Vincent Medical Group Inc.

Located in: Indianapolis, IN USA
  Connect »

MedStar Washington Hospital Center

Located in: Washington, DC USA
  Connect »

STAR Clinical Trials LLC

Located in: San Antonio, TX USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.